Recommendations For Cancer Prevention – Part 2 of 3
Earlier this month, the genetic testing company 23andMe announced it’s no longer donation health information with its home-based kit service after the US Food and Drug Administration warned that the test is a medical device that requires government approval. The redesigned task force recommendations will be published online Dec 23, 2013 in the Annals of Internal Medicine. The task force’s judgment carries heavy weight within the health concern industry.
For instance, the federal government’s list of preventive health care measures that insurers must provide free of charge under the Affordable Care Act is based on USPSTF recommendations. According to the assignment force, about 90 percent of American women do not have a family history associated with an increased risk for BRCA mutations, and even fewer will have a mutation that could lead to breast cancer. “Only two or three women in a thousand have these mutations.
Doing this is not prevalent to prevent most breast cancers”. Medical experts are concerned that many women will undergo unnecessary surgery following an unclear genetic test, having their breasts or ovaries needlessly removed to retard a cancer risk they never had. “All of us have a copy of the BRCA gene, and some of us have a mutation,” said Dr Otis Brawley, chief medical officer of the American Cancer Society.
And “Some mutations expand the risk of breast cancer by up to 85 percent, others by 40 percent, others by 10 percent. But the woman who now knows she has a mutation is very frightened and very upset, and no number of explaining that it’s of little to no significance will help,” Brawley continued. Both Brawley and Moyer emphasized that any woman interested in BRCA screening should meet with a certified genetic counselor before proceeding.